Emoritcha, Antonio V.
HRN: 11-81-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/09/2025
06/15/2025
IVTT
4.5g
Q8
Cap HR
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes